Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed COO
|
|
MyoKardia, Inc. (MYOK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/15/2020 |
GN
| MyoKardia Presents Cardiac Imaging Data from 30-Week EXPLORER-HCM Study of Mavacamten |
| 11/13/2020 |
GN
| MyoKardia Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association's Scientific Sessions 2020 |
| 11/11/2020 |
GN
| MyoKardia Collaborates with the American College of Cardiology and PINNACLE/Veradigm to Launch Patient Registry of Hypertrophic Cardiomyopathy |
| 11/05/2020 |
GN
| MyoKardia Reports Third Quarter 2020 Financial Results |
| 11/04/2020 |
GN
| MyoKardia Announces Awardees of the Second Annual MyoSeeds™ Research Grants Program |
| 10/21/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of CXO, BSTC, MYOK, and CBMG Mergers |
| 10/19/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MYOK, CBMG, CIT, and STND Mergers |
| 10/15/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of Montage Resources Corporation (NYSE: MR), MyoKardia, Inc. (NASDAQ: MYOK), Standard AVB Financial Corp. (NASDAQ GS: STND), and Virtusa Corporation (NASDAQ: VRTU) |
| 10/09/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MYOK, MOBL, WPX, and STND Mergers |
| 10/05/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of MyoKardia, Inc. Buyout |
| 10/05/2020 |
GN
| MYOKARDIA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of MYOK and Encourages Investors to Contact the Firm |
| 08/29/2020 |
GN
| MyoKardia Presents Results from Phase 3 EXPLORER-HCM Clinical Trial of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy |
| 08/11/2020 |
GN
| MyoKardia and LianBio Form Strategic Partnership to Develop and Commercialize Mavacamten Together in Greater China |
| 08/05/2020 |
GN
| MyoKardia to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference |
| 08/04/2020 |
GN
| MyoKardia Reports Second Quarter 2020 Financial Results |
| 08/03/2020 |
GN
| CORRECTION: MyoKardia Doses First Patient in Phase 3 VALOR-HCM Trial of Mavacamten |
| 08/03/2020 |
GN
| MyoKardia Doses First Patient in Phase 3 VALOR-HCM Trial of Mavacamten |
| 07/23/2020 |
GN
| MyoKardia Announces Receipt of Breakthrough Therapy Designation from FDA for Mavacamten for the Treatment of Symptomatic, Obstructive Hypertrophic Cardiomyopathy |
| 07/21/2020 |
GN
| MyoKardia and Fulcrum Therapeutics Announce Multi-Target Collaboration to Discover Novel Targeted Therapies for Genetic Cardiomyopathies |
| 07/21/2020 |
GN
| MyoKardia and Fulcrum Therapeutics Announce Multi-Target Collaboration to Discover Novel Targeted Therapies for Genetic Cardiomyopathies |
| 07/06/2020 |
GN
| MyoKardia Announces Appointment of Denelle J. Waynick as General Counsel and Corporate Secretary |
| 06/22/2020 |
GN
| MyoKardia Announces Positive Data from Phase 2a Clinical Trial of Danicamtiv Presented at ESC's HFA Discoveries with Simultaneous Publication in European Journal of Heart Failure |
| 06/19/2020 |
GN
| MyoKardia Announces Danicamtiv Data Presentation at the European Society of Cardiology's Virtual Heart Failure Association Discoveries |
| 05/12/2020 |
GN
| MyoKardia Announces Pricing of Public Offering of Common Stock |
| 05/11/2020 |
GN
| MyoKardia Announces Primary and All Secondary Endpoints Met in Phase 3 EXPLORER Clinical Trial of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy |
| 03/30/2020 |
GN
| MyoKardia Announces Mavacamten Treatment Well Tolerated and Significantly Reduced Biomarkers of Cardiac Injury and Wall Stress in Non-Obstructive Hypertrophic Cardiomyopathy Patients |
| 03/26/2020 |
GN
| MyoKardia Provides Clinical Trial Update in the Context of the COVID-19 Pandemic |
| 03/19/2020 |
GN
| Data from MAVERICK-HCM Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy Selected for Virtual Late-Breaker Presentation at the American College of Cardiology's 69th Annual Scientific Session Together with World Congress of Cardiology |
| 02/24/2020 |
GN
| MyoKardia to Present at 40th Annual Cowen Health Care Conference |
| 02/20/2020 |
GN
| MyoKardia to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 27, 2020 |
| 01/06/2020 |
GN
| MyoKardia to Present at 38th Annual J.P. Morgan Healthcare Conference |
| 11/27/2019 |
GN
| MyoKardia to Present at Evercore ISI 2nd Annual HealthCONx Conference |
| 11/11/2019 |
GN
| MyoKardia Announces 48-week Data from PIONEER-OLE Study of Mavacamten |
| 11/11/2019 |
GN
| MyoKardia Announces Positive Topline Data from its Phase 2 MAVERICK-HCM Clinical Trial of Mavacamten |
|
|
|